Manufacturing of low titer-blood group O whole blood: Presentation of results at the SABM 2021 Annual Meeting
Glycorex Transplantation AB (publ.), listed on NGM Main Regulated Equity, announces that the Transfusion unit at the University of Rochester Medical Center presents their experience with the UBP-product for the manufacturing of low titer-blood group O whole blood (LTOWB) at the Society for the Advancement of Blood Management (SABM) today.The company has developed a CE-marked medical device for reduction of blood group A and blood group B specific antibodies (UBP-product). Massive bleeding is one of the leading causes of death in severe trauma. Evidence is growing suggesting that